Investorideas podcasts on iTunes, Google Play Music and potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts crypto corner    Play by Play – the latest sports headlines and sports stock news    420 Cannabis Investor Ideas Call us 800 665 0411


Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

ICC International Cannabis Corporation (TSX VENTURE: $ICC.V) Announces New CEO to Support Global Growth Strategy


VANCOUVER, BRITISH COLUMBIA - June 26, 2017 ( Newswire) ICC International Cannabis Corporation ("ICC" or the "Company") (TSX VENTURE:ICC), a fully licensed producer and distributor of medical and recreational cannabis and cannabinoid extracts, today announced the promotion of Mr. Alejandro Antalich to Chief Executive Officer, and the appointment of Mr. Diego Taranto to Senior Financial Controller. These management changes come at a time when the Company is transitioning from an early stage licensed producer to a fully licensed producer and distributor of recreational cannabis in Uruguay. Mr. Guillermo Delmonte has stepped down as CEO effective today and will assist Mr. Antalich in the transition of responsibilities.

"On behalf of the Board of Directors, Management and Staff of ICC, I would like to thank Guillermo for his efforts in establishing ICC as a leading international cannabis producer. We wish him the very best in his future endeavours. I would also like to congratulate Alejandro on assuming the role of CEO, and Diego on joining ICC as our new Senior Financial Controller," commented Michael Galego, Director of the Company. "ICC is entering a stage of rapid growth, with recreational sales in Uruguay commencing in early July and the anticipated expansion into new jurisdictions globally in the coming months. With these management changes ICC now has a senior leadership team with the experience to support both our current business and the successful execution of our long-term strategy of becoming the world's largest and lowest cost producers of cannabidiol ("CBD")."

Mr. Antalich joined ICC in March 2017 as Senior Operations Manager overseeing all research and development team initiatives. In his short tenure with ICC to date, he and his team have successfully constructed the first CBD extraction and oil formulation laboratories in South America. Mr. Antalich brings over 25 years of leadership and operations experience in the healthcare and pharmaceutical industry in Uruguay. Mr. Antalich's appointment as CEO is subject to TSX Venture Exchange ("TSX-V") approval.

Mr. Diego Taranto has been appointed to Senior Financial Controller and will assist our Chief Financial Officer, Oscar Leon, with overall responsibility for financial reporting and planning, treasury, and taxation. Mr. Taranto is a Certified Public Accountant with over 20 years of finance and accounting experience in private companies, with particular expertise in the pharmaceutical and manufacturing sectors.

ICC is also pleased to announce that it has engaged Venture North Capital Inc. ("Venture North") to provide strategic investor relations and shareholder communications services. Venture North is a full service capital markets consulting firm, headquartered in Toronto, Ontario and has experience executing strategic investor relations outreach campaigns on behalf of TSX, TSX-V and CSE listed growth companies. Venture North will be focused on increasing investor awareness while introducing ICC to its network of investment advisors, investment dealers, institutions and other financial professionals. Under the terms of the engagement, which is for an initial six month term, Venture North will be paid $6,000 per month. It will also be granted 150,000 options having an exercise price of $1.40, vesting at a rate of 37,500 immediately and 37,500 thereafter quarterly in arrears. This engagement is subject to TSX-V approval. This engagement is subject to TSX-V approval.


The Company has operations in Uruguay, and is focused on the licensed production, development and sale of recreational cannabis, cannabinoid extracts and other derivatives used for medicinal purposes and industrial hemp. For more information, please see the Company's filings on and

Neither the TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict, including the Company's ability to obtain any requisite regulatory approvals. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company's filings with Canadian securities regulators, which filings are available at

Contact Information

ICC International Cannabis Corporation
Alejandro Antalich
Chief Executive Officer

Bill Mitoulas
Investor Relations

Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Watch the 420 Cannabis Investor video

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Learn more about publishing your news release on the newswire

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy: